ArticleEye (London, England)2025

Efficacy and safety of intravitreal rAAV2-ND4 therapy for Leber's hereditary optic neuropathy.

Libin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.